ADAR1 Capital Management »

Jd shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Jd (JD) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Jd

Tip: Access up to 7 years of quarterly data

All positions including Jd held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jd by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $110k 4.0k 27.39

More positions owned by ADAR1 Capital Management

Cytokinetics Com New (CYTK)
Protagonist Therapeutics (PTGX)
Bridgebio Pharma (BBIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Zura Bio Class A Ord Shs (ZURA)
Zai Lab Adr (ZLAB)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Aa Mission Acquisition Corp Ord Shs Cl A (AAM)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)

View all positions for ADAR1 Capital Management

Top funds holding Jd

Dodge & Cox
Susquehanna International
Yiheng Capital
Jane Street
FMR
Invesco
Goldman Sachs Group
Citadel Advisors
Newlands Management Operations
UBS Group
D. E. Shaw & Co
Fil
Coatue Management
Lazard Asset Management
Appaloosa

View all funds holding Jd